All Stories

  1. Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder

    Article • Current Medical Research and Opinion, September 2018, Taylor & Francis

    Dr. Moriyoshi Yasuda

  2. Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]

    Article • Drug Healthcare and Patient Safety, July 2018, Dove Medical Press

    Dr. Moriyoshi Yasuda

  3. Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial

    Article • Drug Healthcare and Patient Safety, October 2017, Dove Medical Press

    Dr. Moriyoshi Yasuda

  4. Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study)

    Article • Hepatology Research, February 2017, Wiley

    Dr. Moriyoshi Yasuda